Dendreon May Open Atlanta Plant
Eric Hal Schwartz7/17/09
Dendreon, the Seattle-based cancer drug developer, may open a new manufacturing plant in Georgia, according to a report in the Atlanta Business Chronicle. Dendreon’s product, a new drug to treat prostate cancer, is being reviewed for approval by the FDA. Xconomy has written about Dendreon’s limited manufacturing before. The possible plant could cost $80 million and create more than 300 jobs in Atlanta. Currently, Dendreon has a commercial manufacturing plant in Morris Plains, NJ.
Eric Hal Schwartz was an intern in Xconomy's Seattle office.





News, Money and Drugs for Monday, July 20, 2009 « IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes Sneaky
7/20/09 5:44 pm
[...] 300 new jobs in Atlanta? Maybe, says Dendreon (DNDN). [Xconomy] [...]